‘March-in’ rights: Why Biden’s changes contradict the point of Bayh-Dole

It's a striking show of unity. Nine former senior officials from the US Department of Commerce spanning more than 20 years and five administrations—both Democratic and Republican—have joined forces to write to President Biden.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Pharma industry pushes back on Biden’s ‘dangerous’ plan

19 December 2023 The Biden administration’s proposals target price gouging triggers resistance | The move, which includes the consideration of march-in rights for taxpayer-funded drugs, may ‘jeopardise collaborative partnerships and hinder innovation.

Big Pharma

House passes Biden-backed orphan drug reform

23 May 2021 The US House of Representatives has passed a bill to amend exclusivity laws for drugs on the US Food and Drug Administration’s orphan drugs list.

More on this story

Big Pharma

House passes Biden-backed orphan drug reform

23 May 2021 The US House of Representatives has passed a bill to amend exclusivity laws for drugs on the US Food and Drug Administration’s orphan drugs list.

Big Pharma

Pharma industry pushes back on Biden’s ‘dangerous’ plan

More on this story

Big Pharma

House passes Biden-backed orphan drug reform

23 May 2021 The US House of Representatives has passed a bill to amend exclusivity laws for drugs on the US Food and Drug Administration’s orphan drugs list.

Big Pharma

Pharma industry pushes back on Biden’s ‘dangerous’ plan